Report #2829493

Overview

Sex

Female

Age

Age unknown

State

MN

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

Patient took first two capsules on two consecutive days; Case reference number US-BN-2024-000675 is a spontaneous case report initially received from a pharmacist via Med Communication (reference number: USBAV24-0560) on 25-Mar-2024 and concerns a female patient of unspecified age. The patient's relevant medical history and concomitant medications were not provided. It was reported that patient did not read the instructions and patient took first two capsules of Vivotif (batch number: Unknown), on two consecutive days, orally, for unknown indication (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. No further information provided.; Reporter's Comments: A female patient of unspecified age did not read the instructions and took first two capsules of Vivotif, on two consecutive days, for unknown indication, which is considered as inappropriate schedule of vaccine administered. No associated adverse events were reported. Inappropriate schedule of vaccine administered is listed per company convention. The patient's relevant medical history and concomitant medications were not provided. Inappropriate schedule of vaccine administered is not related to Vivotif, but to a human factor. The case is non-serious.; Sender's Comments: A female patient of unspecified age did not read the instructions and took first two capsules of Vivotif, on two consecutive days, for unknown indication, which is considered as inappropriate schedule of vaccine administered. No associated adverse events were reported. Inappropriate schedule of vaccine administered is listed per company convention. The patient's relevant medical history and concomitant medications were not provided. Inappropriate schedule of vaccine administered is not related to Vivotif, but to a human factor. The case is non-serious.

Medical history

Comments: None